Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Bupropion SR | Canagliflozin | |
|---|---|---|
| Category | Pharmaceuticals | Pharmaceuticals |
| Standard Dose | — | — |
| Timing | — | — |
| Cycle Duration | — | — |
| Evidence Level | Strong | Moderate (longevity), Strong (cardiorenal) |
Norepinephrine-dopamine reuptake inhibitor used clinically for mood, motivation, and smoking cessation.
SGLT2 inhibitor originally developed for type 2 diabetes. Blocks glucose reabsorption in kidneys, creating a mild glucose deficit that activates AMPK and mimics caloric restriction. Extended lifespan in male mice in the ITP.
Fast buy links (we may earn a small commission at no extra cost).
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →